DaVita Inc (DVA)

Industry Medical Care Facilities

This stock can be held in an Investment ISA and an Investment Account

Sell

$155.55

Buy

$157.82

arrow-up$2.15 (+1.40%)

Prices updated at 12 Apr 2025, 00:42 EDT

Prices minimum 15 mins delay

Prices in USD

DaVita Inc is engaged in operating kidney dialysis centers and providing related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives.

S&P 500

1.81%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Medical Care Facilities

Chairman

Ms. Pamela M. Arway

CEO

Mr. Javier J. Rodriguez

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

76,000

Head office

2000 16th Street

Denver

United States

80202

+1 720 631-2100

ir@davita.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Ms. Barbara J. Desoer Independent Director	0.19m
Mr. Charles G. Berg Independent Director	0.12m
Mr. Javier J. Rodriguez Director and Chief Executive Officer	1.41m
Mr. Joel Ackerman Chief Financial Officer and Treasurer	0.70m
Ms. Phyllis R. Yale Independent Director	0.18m
Mr. Adam H. Schechter Independent Director	0.14m
Ms. Wendy L. Schoppert Independent Director	0.06m
Ms. Pamela M. Arway Chairman of the Board	0.30m
Mr. Michael David Staffieri Chief Operating Officer Emeritus	0.80m
Mr. Christopher M. Berry Chief Accounting Officer	-
Mr. Jason M. Hollar Independent Director	0.17m
Mr. Gregory J Moore Independent Director	0.16m
Mr. Dennis W. Pullin Director	-
Mr. David P. Maughan Chief Operating Officer, DaVita Kidney Care	-
Ms. Kathleen Alyce Waters Chief Legal and Public Affairs Officer	0.68m
Mr. James O. Hearty Chief Compliance Officer	0.50m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Berkshire Hathaway Inc	36,095,570
Vanguard Group Inc	5,214,815
BlackRock Inc	4,233,400
State Street Corp	2,343,728
BlackRock Fund Advisors	1,810,670

Director dealings

Date chevron-l-regular chevron-r-regular	Action
02 Dec 2024	-
27 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
27 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
15 Nov 2024	-
16 Sep 2024	-
16 Sep 2024	-
16 Sep 2024	-
16 Sep 2024	-
16 Sep 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.